Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on North America Non-invasive Aesthetic Treatment Market
5.1. COVID-19 Landscape: North America Non-invasive Aesthetic Treatment Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global North America Non-invasive Aesthetic Treatment Market, By Procedure
8.1. North America Non-invasive Aesthetic Treatment Market, by Procedure, 2022-2030
8.1.1. Injectables
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Skin Rejuvenation
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global North America Non-invasive Aesthetic Treatment Market, By End-use
9.1. North America Non-invasive Aesthetic Treatment Market, by End-use, 2022-2030
9.1.1. Hospital/Surgery Center
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Medspa
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Traditional Spa
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. HCP owned clinic
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global North America Non-invasive Aesthetic Treatment Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Procedure (2017-2030)
10.1.2. Market Revenue and Forecast, by End-use (2017-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Procedure (2017-2030)
10.1.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Procedure (2017-2030)
10.1.4.2. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 11. Company Profiles
11.1. Toronto Cosmetic Clinic (TCC)
11.1.1. Company Overview
11.1.2. Procedure Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. The Cosmetic Clinic
11.2.1. Company Overview
11.2.2. Procedure Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Skinovative of Gilbert-Medical Spa
11.3.1. Company Overview
11.3.2. Procedure Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Shea Aesthetic Clinic
11.4.1. Company Overview
11.4.2. Procedure Offerings
11.4.3. Financial Performance
11.4.4. LTE Scientific
11.5. Chapter Aesthetic Studio
11.5.1. Company Overview
11.5.2. Procedure Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. AnewSkin Medspa
11.6.1. Company Overview
11.6.2. Procedure Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. The Ottawa Skin Clinic
11.7.1. Company Overview
11.7.2. Procedure Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Manhattan Aesthetics
11.8.1. Company Overview
11.8.2. Procedure Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Toronto Medical Aesthetics
11.9.1. Company Overview
11.9.2. Procedure Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Dr. Cory Torgerson
11.10.1. Company Overview
11.10.2. Procedure Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms